Opko And Pfizer Enter Into Partnership Agreement For Growth Hormone Deficiency

Opko to receive upfront payment of $295M and up to potential milestone payments of $275M for GHD drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.